Cigna sues Celgene, Bristol Myers over $2.25 billion US drug monopoly, pay for delay
The Cigna Group has filed a US antitrust complaint against drug manufacturer Celgene and its parent company Bristol Myers, alleging the defendants shielded a $2.25 billion-per-year monopoly in the market for...To view the full article, register now.
Already a subscriber? Click here to view full article